Cancer Therapy News and Research

RSS

'Navigators' may offer path to improved diagnosis, treatment outcomes for Indigenous cancer patients

New research shows that patient "navigators" are a valuable resource for American Indians and Alaskan Natives with cancer as they try to overcome barriers to diagnosis and care, and may offer a path to improved treatment outcomes.

25 Jan 2017

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Wilfried Weber, Professor of Synthetic Biology at the University of Freiburg, has received a grant of roughly €150,000 for his project "Hide and Seek with Cancer Drugs" in which he is working to improve the drugs used in cancer treatment

25 Jan 2017

Scientists discover cause of tumour resistance to angiogenesis inhibitors

A new study conducted by MedUni Vienna in collaboration with scientists from Hungary and Sweden has now shown for the first time that the success of specialised drugs to inhibit blood supply to tumours - so-called angiogenesis inhibitors - is compromised by the fact that these drugs do not effectively penetrate the tumour tissue and so do not reach the smallest blood vessels in the tumour.

25 Jan 2017

Study: Half of women treated for early stage breast cancer report severe side effects

Nearly half of women treated for early stage breast cancer reported at least one side effect from their treatment that was severe or very severe, a new study finds.

24 Jan 2017

Researchers explore feasibility of carbon ions for treating cardiac arrhythmia

Approximately 350,000 patients in Germany suffer from various forms of cardiac arrhythmia. The condition can lead to permanent damage as a result of stroke, or it may cause sudden heart failure.

24 Jan 2017

New biomarker helps better predict survival after surgical removal of colorectal metastases

Liver metastases are formed from cancer cells that have originated in other organs and migrated to the liver via the bloodstream. Colorectal cancer (cancer of the colon/rectum) can be successfully treated by surgical resection of the metastases in combination with chemotherapy.

23 Jan 2017

Biosimilars create chances to improve sustainability and affordability of cancer treatment

Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open.

18 Jan 2017

Research offers new clues to prolong lifespan of the body's disease-fighting NK cells

A team of researchers from Australia and France have uncovered new insights into how to prolong the lifespan of the body's disease-fighting natural killer (NK) cells.

17 Jan 2017

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Massachusetts General Hospital investigators have identified a protein that may play an essential role in maintaining a population of tumor-initiating cells (TICs) -- treatment-resistant cells responsible for cancer recurrence and metastasis -- in breast cancer, as well as a compound that appears to reduce the molecule's ability to protect TICs from the effects of chemotherapy.

17 Jan 2017

Researchers discover underlying cause for formation of granulomas

Granulomas are tissue nodules of immune cells that occur in diseases such as tuberculosis and sarcoidosis and can damage many organs.

16 Jan 2017

Roswell Park study provides new insights into gene mutations that can lead to cancer

Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates of genetic damage.

11 Jan 2017

NCI launches new drug formulary to help expedite use of agents in clinical studies

The National Cancer Institute today launched a new drug formulary (the "NCI Formulary") that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.

11 Jan 2017

Study finds decline in rate of prostate cancer treatment after change in screening recommendations

As some national guidelines now recommend against routine prostate cancer screening, the overall rate of men receiving treatment for the disease declined 42 percent, a new study finds.

10 Jan 2017

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Researchers at Okayama University have uncovered a potential new therapeutic target for invasive bladder cancer. The GTP hydrolysing enzyme (GTPase), called Dynamin2, facilitates the rapid invasion of cancer into surrounding tissues; inhibiting its activity could limit the progression of bladder cancer.

10 Jan 2017

Scientists gain new insights into molecular mechanisms of breast cancer development

Why does breast cancer develop and how come certain patients are resistant to established therapies? Researchers from the University of Basel have gained new insights into the molecular processes in breast tissue.

9 Jan 2017

UI scientists reveal how high-dose vitamin C damages cancer cells

Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.

9 Jan 2017

Research findings may provide new treatment for prevention of cancer metastasis

Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.

9 Jan 2017

Regular aspirin use lowers pancreatic cancer risk by 50%, new study finds

The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.

6 Jan 2017

Yale study highlights treatment burden experienced by older lung cancer patients

Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according to a study by Yale researchers.

6 Jan 2017

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

Scientists have revealed how cancer cells are able to break free of the physical restraints imposed by their surroundings in order to grow and spread around the body.

5 Jan 2017

Cancer Therapy News and Research

'Navigators' may offer path to improved diagnosis, treatment outcomes for Indigenous cancer patients

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Scientists discover cause of tumour resistance to angiogenesis inhibitors

Study: Half of women treated for early stage breast cancer report severe side effects

Researchers explore feasibility of carbon ions for treating cardiac arrhythmia

New biomarker helps better predict survival after surgical removal of colorectal metastases

Biosimilars create chances to improve sustainability and affordability of cancer treatment

Research offers new clues to prolong lifespan of the body's disease-fighting NK cells

MGH researchers identify protein that may protect tumor-initiating cells in breast cancer

Researchers discover underlying cause for formation of granulomas

Roswell Park study provides new insights into gene mutations that can lead to cancer

NCI launches new drug formulary to help expedite use of agents in clinical studies

Study finds decline in rate of prostate cancer treatment after change in screening recommendations

Okayama University researchers uncover potential new therapeutic target for invasive bladder cancer

Scientists gain new insights into molecular mechanisms of breast cancer development

UI scientists reveal how high-dose vitamin C damages cancer cells

Research findings may provide new treatment for prevention of cancer metastasis

Regular aspirin use lowers pancreatic cancer risk by 50%, new study finds

Yale study highlights treatment burden experienced by older lung cancer patients

Study reveals how cancer cells break free of physical restraints to grow and spread in the body

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News